Literature DB >> 28456915

Reversible Cerebral Vasoconstriction Syndrome: Recognition and Treatment.

Cecilia Cappelen-Smith1,2,3, Zeljka Calic4,5,6, Dennis Cordato4,5,6.   

Abstract

OPINION STATEMENT: Reversible cerebral vasoconstriction syndrome (RCVS) is a rare but increasingly recognized disorder with over 500 cases published in the literature. The condition is characterized by recurrent severe thunderclap headaches with or without other neurological symptoms and diffuse segmental narrowing of the cerebral arteries which is reversible within 3 months. RCVS may occur spontaneously but in over 50% of cases, it is associated with various other conditions, including vasoactive medications or illicit drugs and the post-partum state. One third to a half of cases develop hemorrhagic or ischemic brain lesions or a combination of both. Posterior reversible encephalopathy syndrome (PRES) often occurs in association with RCVS and the conditions are likely to share a common pathophysiology. The pathogenesis of RCVS remains uncertain but autonomic dysregulation, oxidative stress, and genetic predisposition are postulated. Significant differential diagnoses include subarachnoid hemorrhage (SAH) due to aneurysmal rupture, cervical artery dissection, and primary angiitis of the central nervous system (PACNS). Although there is no proven treatment, calcium channel antagonists including nimodipine and verapamil have been administered with reported reduction of headache intensity but without effect on the time course of cerebral vasoconstriction. Glucocorticoids have been reported as an independent predictor of worse outcome and should be avoided. The cornerstone of RCVS management remains largely supportive with bed rest and analgesics and removal of precipitating factors. Invasive neurointerventional techniques should be reserved for severe deteriorating cases. The condition is usually benign and self-limited and the majority of patients have a favorable outcome but around 5-10% are left with permanent neurological deficits and rare cases may die. This review details the importance of the early recognition of this increasingly described condition and current treatment recommendations.

Entities:  

Keywords:  Posterior reversible encephalopathy syndrome; Primary angiitis of the central nervous system; Reversible cerebral vasoconstriction syndrome; Thunderclap headache

Year:  2017        PMID: 28456915     DOI: 10.1007/s11940-017-0460-7

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  57 in total

Review 1.  Narrative review: reversible cerebral vasoconstriction syndromes.

Authors:  Leonard H Calabrese; David W Dodick; Todd J Schwedt; Aneesh B Singhal
Journal:  Ann Intern Med       Date:  2007-01-02       Impact factor: 25.391

2.  Reversible postpartum cerebral vasoconstriction syndrome-reply.

Authors:  Jennifer E Fugate; Eelco F M Wijdicks; Alejandro A Rabinstein
Journal:  Arch Neurol       Date:  2012-06-01

3.  Hemorrhagic Reversible Cerebral Vasoconstriction Syndrome: Features and Mechanisms.

Authors:  Mehmet A Topcuoglu; Aneesh B Singhal
Journal:  Stroke       Date:  2016-06-07       Impact factor: 7.914

Review 4.  Reversible cerebral vasoconstriction syndrome.

Authors:  Z Calic; C Cappelen-Smith; A S Zagami
Journal:  Intern Med J       Date:  2015-06       Impact factor: 2.048

Review 5.  Reversible segmental cerebral arterial vasospasm and cerebral infarction: possible association with excessive use of sumatriptan and Midrin.

Authors:  J F Meschia; M D Malkoff; J Biller
Journal:  Arch Neurol       Date:  1998-05

Review 6.  Reversible Cerebral Vasoconstriction Syndrome Without Typical Thunderclap Headache.

Authors:  Valérie Wolff; Anne Ducros
Journal:  Headache       Date:  2016-03-26       Impact factor: 5.887

7.  Long-term outcomes after reversible cerebral vasoconstriction syndrome.

Authors:  Seby John; Aneesh B Singhal; Leonard Calabrese; Ken Uchino; Tariq Hammad; Stewart Tepper; Mark Stillman; Brittany Mills; Tijy Thankachan; Rula A Hajj-Ali
Journal:  Cephalalgia       Date:  2015-06-18       Impact factor: 6.292

Review 8.  Posterior reversible encephalopathy syndrome.

Authors:  C Lamy; C Oppenheim; J L Mas
Journal:  Handb Clin Neurol       Date:  2014

9.  Reversible cerebral vasoconstriction syndrome following indomethacin.

Authors:  Zeljka Calic; Ho Choong; Glen Schlaphoff; Cecilia Cappelen-Smith
Journal:  Cephalalgia       Date:  2014-04-10       Impact factor: 6.292

10.  Benign angiopathy: a distinct subset of angiographically defined primary angiitis of the central nervous system.

Authors:  L H Calabrese; L A Gragg; A J Furlan
Journal:  J Rheumatol       Date:  1993-12       Impact factor: 4.666

View more
  19 in total

Review 1.  Haemorrhagic stroke related to the use of 4-fluoroamphetamine.

Authors:  C H W Wijers; M C Visser; R T H van Litsenburg; R J M Niesink; R B Willemse; Esther A Croes
Journal:  J Neurol       Date:  2018-05-08       Impact factor: 4.849

2.  Intra-Arterial Verapamil Treatment in Oral Therapy-Refractory Reversible Cerebral Vasoconstriction Syndrome.

Authors:  J M Ospel; C H Wright; R Jung; L L M Vidal; S Manjila; G Singh; D V Heck; A Ray; K A Blackham
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-26       Impact factor: 3.825

3.  Recurrent thunderclap headaches from reversible cerebral vasoconstriction syndrome associated with duloxetine, xylometazoline and rhinitis medicamentosa.

Authors:  Hoang Pham; Stéphanie Gosselin-Lefebvre; Persia Pourshahnazari; Samuel Yip
Journal:  CMAJ       Date:  2020-11-09       Impact factor: 8.262

Review 4.  Reversible Cerebral Vasoconstriction Syndrome in the Postpartum Period: A Systematic Review and Meta-Analysis.

Authors:  Kimberly Pacheco; Juan Fernando Ortiz; Jashank Parwani; Claudio Cruz; Mario Yépez; Maja Buj; Mahika Khurana; Diego Ojeda; Alisson Iturburu; Alex S Aguirre; Ray Yuen; Shae Datta
Journal:  Neurol Int       Date:  2022-05-31

5.  Oxygen extraction fraction (OEF) assesses cerebral oxygen metabolism of deep gray matter in patients with pre-eclampsia.

Authors:  Linfeng Yang; Junghun Cho; Tao Chen; Kelly M Gillen; Jing Li; Qihao Zhang; Lingfei Guo; Yi Wang
Journal:  Eur Radiol       Date:  2022-03-29       Impact factor: 7.034

6.  Reversible cerebral vasoconstriction syndrome presenting as an isolated primary intraventricular hemorrhage.

Authors:  Katarina Dakay; Ryan A McTaggart; Mahesh V Jayaraman; Shadi Yaghi; Linda C Wendell
Journal:  Chin Neurosurg J       Date:  2018-06-04

Review 7.  Assessment of acute headache in adults - what the general physician needs to know.

Authors:  Krishna Chinthapalli; Anne-Marie Logan; Rohit Raj; Niranjanan Nirmalananthan
Journal:  Clin Med (Lond)       Date:  2018-10       Impact factor: 2.659

8.  Reversible Cerebral Vasoconstriction Syndrome Responsive to Intravenous Milrinone.

Authors:  Maximiliano A Hawkes; Alejandro A Hlavnicka; Nestor A Wainsztein
Journal:  Neurocrit Care       Date:  2020-02       Impact factor: 3.210

Review 9.  CNS Vasculitis: an Approach to Differential Diagnosis and Management.

Authors:  Kevin Byram; Rula A Hajj-Ali; Leonard Calabrese
Journal:  Curr Rheumatol Rep       Date:  2018-05-30       Impact factor: 4.686

10.  Posterior reversible encephalopathy syndrome complicated with subarachnoid hemorrhage in an eclamptic pregnant patient: case report.

Authors:  Dan Hu; Jing Xiong; Yunfei Zha; Zhaohui Zhang
Journal:  BMC Neurol       Date:  2018-11-03       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.